 | Contact UsEmail: iaih[at]ccamp[dot]res[dot]in |
Outcomes:
Contributing towards reducing the AMR burden in India and beyond.
Deliver specific interventions to lower the projected mortality burden in India.
Enhance investments to combat AMR in India.
IAIH will prioritize key areas through stakeholder engagement and a multi-pronged approach that aligns with the National Action Plan (NAP) on AMR, The Global Action Plan on AMR, and the mandates of the stakeholders.
The IAIH's mandate is fulfilled by five Special Interest Groups (SIGs), subsets of the Advisory Council, each focusing on:
• Problem Identification
• Solution Articulation
• Collective Implementation
• Systemic Integration
Create a common platform to drive AMR-focused research, innovation, policy, and action to support national efforts to reduce AMR in India and beyond.
Collaborate with multiple stakeholders across the public health ecosystem for expertise, resources, and convergence of mandates to enable collective and collaborative action.
Address AMR through trans-disciplinary, multi-sectoral, and inclusive or holistic approaches.
Launched in November 2021, India AMR Innovation Hub (IAIH) works in tandem with several key Indian and global stakeholders from Government, Academia, Industry, Philanthropic, Startups, and not-for-profit organisations.
IAIH will prioritise key areas through stakeholder engagement and a multi-pronged approach that aligns with the National Action Plan (NAP) on AMR, the Global Action Plan (GAP) on AMR, and the stakeholders' mandate.
Antimicrobial Resistance (AMR) is a major global health threat that has caused more deaths than HIV/AIDS and malaria worldwide in 2019, as per recent studies.
Projections show that AMR-related mortality will reach 10 million annually by 2050 globally, with India alone accounting for 2 million.
IAIH gathered input on the National Action Plan (2017-22) from its partners and stakeholders to develop the next five-year plan (2022-26) for AMR.
The detailed report includes recommendations on various policy implementation, assessment, ownership, and global integration aspects of India's AMR efforts from a multi-sectoral perspective, ultimately accelerating on-ground impact.
1st India Antimicrobial Resistance (AMR) Innovation Workshop
2nd India Antimicrobial Resistance (AMR) Innovation Workshop
The IAIH is conceived and driven by the Centre for Cellular and Molecular Platforms (C-CAMP), a premier technology, bio innovation, and entrepreneurship ecosystem based in Bengaluru, India.
IAIH envisions a converging and collaborative platform for national and global stakeholders to curtail AMR in India through active participation and gradually tackle this global health challenge.
The mission is to integrate necessary interventions for enabling the AMR Innovation Ecosystem, such as developing public health policy, capability and capacity building, AMR stewardship, and public communication.
India AMR Innovation Hub, IAIH is an initiative conceptualised and anchored by C-CAMP and governed by an Advisory Council with Principal Scientific Adviser to the Govt of India as Chair.
Launched in 2021, IAIH is a unique think tank for Antimicrobial Resistance (AMR) interventions bringing together stakeholders across the AMR ecosystem, both Indian and global, and across Government, Academia, Industry, Philanthropic, and not-for-profit organizations. It envisages a convergent platform for multi-stakeholder engagement and a multi-pronged approach to key areas of AMR intervention, prioritized in alignment with the National Action Plan on AMR, the Global Action Plan for AMR, and the stakeholders’ mandate.
IAIH initiatives
C-CAMP is part of the Global Accelerator Network GAN set up by, USA-based Combating Antibiotic-Resistant Bacteria - X (CARB-X). CARB-X is the world’s largest public-private-partnership to fund AMR solutions across the world. C-CAMP currently supports several ventures that seek to tackle AMR with a focus on ESKAPE pathogens in human/clinical settings.
C-CAMP in partnership with Indian philanthropy SBI Foundation has invested in startups active in both human and animal health sectors of AMR.
C-CAMP partners with the UK Department of Health and Social Care’s Global AMR Innovation Fund (GAMRIF) to nurture and fund innovations to address antimicrobial resistance in the environment with a special focus on addressing challenges in low- and middle-income countries (LMICs) with local, contextual solutions.
C-CAMP and Denmark based International Centre for Antimicrobial Resistance Solutions (ICARS) are partnering to provide funding support, technical knowhow, deployment and scale up of mid-to-late stage startups with AMR solutions focusing on the multi-sectoral One Health domain.
To read the "Compendium of IAIH Innovations" - View Now
"introduction": {
"heading": "Introduction"
},
"clusters": {
"heading": "S&T Clusters In India",
"subheading": "Clusters"
},
"clusterNews":{
"heading": "S&T Cluster Activities",
"link": {
"uri": "/innovation-science-bharat/industry-partners",
"title": "View All",
"type": "internal"
}
},
"upcomingEvents": {
"heading": "Upcoming Challenges and Events",
"link": null
},
"otherInfo": {
"normal": "Additional Information",
"colored": null
},
"publications": {
"normal": "Call for Proposals",
"colored": null
},
"publicationsArchive": {
"normal": "Archive",
"colored": null
},
"team": {
"normal": "Meet The Team",
"colored": null
}
}
